Filing metadata

Accession number
0001714899-22-000061
Form type
Form 4
Filer
Denali Therapeutics Inc.
CIK
CIK 1714899
Filed
Mar 25, 2022
Reporting period
Mar 23, 2022
Description
Insider transaction

Explore SEC Filings Hub